Annual Total Long Term Liabilities
$9.03 M
-$186.65 M-95.38%
31 December 2023
Summary:
Lexeo Therapeutics Common Stock annual total long term liabilities is currently $9.03 million, with the most recent change of -$186.65 million (-95.38%) on 31 December 2023. During the last 3 years, it has fallen by -$25.21 million (-73.62%). LXEO annual total long term liabilities is now -95.38% below its all-time high of $195.68 million, reached on 31 December 2022.LXEO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$7.72 M
-$461.00 K-5.63%
30 September 2024
Summary:
Lexeo Therapeutics Common Stock quarterly total long term liabilities is currently $7.72 million, with the most recent change of -$461.00 thousand (-5.63%) on 30 September 2024. Over the past year, it has dropped by -$186.78 million (-96.03%). LXEO quarterly long term liabilities is now -96.05% below its all-time high of $195.68 million, reached on 31 December 2022.LXEO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXEO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -95.4% | -96.0% |
| 3 y3 years | -73.6% | - |
| 5 y5 years | - | - |
LXEO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -95.4% | at low | -96.0% | at low |
| 5 y | 5 years | -95.4% | at low | -96.0% | at low |
| alltime | all time | -95.4% | at low | -96.0% | at low |
Lexeo Therapeutics Common Stock Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.72 M(-5.6%) |
| June 2024 | - | $8.18 M(-5.1%) |
| Mar 2024 | - | $8.63 M(-4.5%) |
| Dec 2023 | $9.03 M | $9.03 M(-95.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $194.50 M(-0.2%) |
| June 2023 | - | $194.90 M(-0.4%) |
| Dec 2022 | $195.68 M(+5.8%) | $195.68 M |
| Dec 2021 | $185.01 M(+440.2%) | - |
| Dec 2020 | $34.25 M | - |
FAQ
- What is Lexeo Therapeutics Common Stock annual total long term liabilities?
- What is the all time high annual total long term liabilities for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock annual total long term liabilities year-on-year change?
- What is Lexeo Therapeutics Common Stock quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Lexeo Therapeutics Common Stock?
- What is Lexeo Therapeutics Common Stock quarterly long term liabilities year-on-year change?
What is Lexeo Therapeutics Common Stock annual total long term liabilities?
The current annual total long term liabilities of LXEO is $9.03 M
What is the all time high annual total long term liabilities for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high annual total long term liabilities is $195.68 M
What is Lexeo Therapeutics Common Stock annual total long term liabilities year-on-year change?
Over the past year, LXEO annual total long term liabilities has changed by -$186.65 M (-95.38%)
What is Lexeo Therapeutics Common Stock quarterly total long term liabilities?
The current quarterly long term liabilities of LXEO is $7.72 M
What is the all time high quarterly long term liabilities for Lexeo Therapeutics Common Stock?
Lexeo Therapeutics Common Stock all-time high quarterly total long term liabilities is $195.68 M
What is Lexeo Therapeutics Common Stock quarterly long term liabilities year-on-year change?
Over the past year, LXEO quarterly total long term liabilities has changed by -$186.78 M (-96.03%)